blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2451273

EP2451273 - COMPOSITIONS AND METHODS FOR INHIBITION OF CANCERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.09.2014
Database last updated on 22.08.2024
Most recent event   Tooltip19.09.2014Application deemed to be withdrawnpublished on 22.10.2014  [2014/43]
Applicant(s)For all designated states
The Ohio State University Research Foundation
1524 North High Street
Columbus, OH 43201 / US
[2013/31]
Former [2012/20]For all designated states
The Ohio State University Research Foundation
1216 Kinnear Road
Columbus, OH 43212 / US
Inventor(s)01 / KUPPUSAMY, Periannan
6971 Cunningham Drive
New Albany, OH 43054 / US
02 / KALMAN, Hideg
Ifjuság Str 5/a
H-7624 Pécs / HU
 [2012/20]
Representative(s)Turner, Craig Robert
AA Thornton IP LLP
8th Floor, 125 Old Broad Street
London EC2N 1AR / GB
[N/P]
Former [2012/20]Turner, Craig Robert
A.A. Thornton & Co.
235 High Holborn
London WC1V 7LE / GB
Application number, filing date10797742.306.07.2010
WO2010US41103
Priority number, dateUS20090223283P06.07.2009         Original published format: US 223283 P
[2012/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011005790
Date:13.01.2011
Language:EN
[2011/02]
Type: A1 Application with search report 
No.:EP2451273
Date:16.05.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 13.01.2011 takes the place of the publication of the European patent application.
[2012/20]
Search report(s)International search report - published on:US13.01.2011
(Supplementary) European search report - dispatched on:EP12.11.2012
ClassificationIPC:A01N43/40, A61K31/445, A61P35/00, A61K31/454
[2012/50]
CPC:
A61K31/454 (EP,US); A61P35/00 (EP)
Former IPC [2012/20]A01N43/40, A61K31/445
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/20]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR KREBSVERHINDERUNG[2012/20]
English:COMPOSITIONS AND METHODS FOR INHIBITION OF CANCERS[2012/20]
French:COMPOSITIONS ET PROCÉDÉS POUR L'INHIBITION DE CANCERS[2012/20]
Entry into regional phase13.01.2012National basic fee paid 
13.01.2012Search fee paid 
13.01.2012Designation fee(s) paid 
13.01.2012Examination fee paid 
Examination procedure13.01.2012Examination requested  [2012/20]
24.09.2013Amendment by applicant (claims and/or description)
20.12.2013Despatch of a communication from the examining division (Time limit: M04)
01.05.2014Application deemed to be withdrawn, date of legal effect  [2014/43]
28.05.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/43]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.12.2013
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
24.09.2013Request for further processing filed
24.09.2013Full payment received (date of receipt of payment)
Request granted
07.10.2013Decision despatched
Fees paidRenewal fee
25.07.2012Renewal fee patent year 03
29.07.2013Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.201405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - TONG LIYUE ET AL, "Safe and Targeted Anti-Tumor (STAT) Therapeutics by Difluoroketones: a Novel Drug-Design Targeting the STAT3 Pathway in the Treatment of Ovarian Cancer", FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE, US, (20080101), vol. 45, no. suppl.1, ISSN 0891-5849, page S51, XP008157664 [X] 1-16 * the whole document *
 [XP]  - SELVENDIRAN KARUPPAIYAH ET AL, "Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells", FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE, US, (20100101), vol. 48, no. 9, doi:10.1016/J.FREERADBIOMED.2010.02.009, ISSN 0891-5849, pages 1228 - 1235, XP008157654 [XP] 1-16 * page 1231, column 1, paragraph 1 * * page 1 * * page 1234, column 1, paragraph 1 - paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.freeradbiomed.2010.02.009
International search[Y]US2004176384  (SNYDER JAMES P [US], et al);
 [A]US2008280890  (PATIL GHANSHYAM [US])
 [X]  - SELVENDIRAN ET AL., "Inhibition of Vascular Smooth-Muscle Cell Proliferation and Arterial Restenosis by HO-3867, a Novel Synthetic Curcuminoid, through Up-Regulation of PTEN Expression.", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, (2009), vol. 329, no. 3, pages 959 - 966, XP008148828

DOI:   http://dx.doi.org/10.1124/jpet.108.150367
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.